loader

MeiraGTx Holdings plc

NASDAQ:MGTX:US
Featured Articles and Interviews

Biotech and Pharma Market Update: Q1 2025 in Review

Press Releases

MeiraGTx Reports First Quarter 2024 Financial and Operational Results

MeiraGTx to Participate in Upcoming Investor Conferences

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, and European Union.

Interactive Chart

×